NCT05599984 2025-10-20Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid TumorsAbbViePhase 1 Active not recruiting288 enrolled
NCT06577987 2025-09-15Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesCircle PharmaPhase 1 Recruiting220 enrolled
NCT06936735 2025-04-20Phase I Study of HS-20108 in Participants With Advanced Solid TumorsHansoh BioMedical R&D CompanyPhase 1 Not yet recruiting502 enrolled
NCT05619744 2025-03-10A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine CarcinomasHoffmann-La RochePhase 1 Completed41 enrolled
NCT04514497 2025-03-06Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting28 enrolled
NCT00926640 2018-10-19A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersNational Institutes of Health Clinical Center (CC)Phase 1 Completed28 enrolled
NCT00423254 2010-08-03Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.Mannkind CorporationPhase 1 Completed12 enrolled